$PRTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Paratek Pharmaceuticals, Inc.. Get notifications about new insider transactions in Paratek Pharmaceuticals, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 60,000 | 0 | 273,480 | 213.5 K to 273.5 K (+28.11 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 36,250 | 0 | 213,480 | 177.2 K to 213.5 K (+20.45 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 9.82 | 8,750 | 85,925 | 131,667 | 140.4 K to 131.7 K (-6.23 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 27,500 | 0 | 140,417 | 112.9 K to 140.4 K (+24.35 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 23,750 | 0 | 112,917 | 89.2 K to 112.9 K (+26.64 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 9.82 | 7,579 | 74,426 | 119,504 | 127.1 K to 119.5 K (-5.96 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 27,500 | 0 | 127,083 | 99.6 K to 127.1 K (+27.62 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 22,500 | 0 | 99,583 | 77.1 K to 99.6 K (+29.19 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 9.82 | 8,861 | 87,015 | 281,425 | 290.3 K to 281.4 K (-3.05 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 55,000 | 0 | 290,286 | 235.3 K to 290.3 K (+23.38 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 32,500 | 0 | 235,286 | 202.8 K to 235.3 K (+16.03 %) |
| Jul 05 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 9.97 | 12,000 | 119,640 | 202,786 | 214.8 K to 202.8 K (-5.59 %) |
| Jul 05 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 9.97 | 7,323 | 73,010 | 62,274 | 69.6 K to 62.3 K (-10.52 %) |
| Jul 05 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 9.97 | 22,500 | 224,325 | 177,230 | 199.7 K to 177.2 K (-11.27 %) |
| May 02 2018 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Option Exercise | A | 10.70 | 10,000 | 107,000 | 10,000 | |
| May 02 2018 | PRTK | Paratek Pharmaceut ... | Hoffmann Rolf K | Director | Grant | A | 0.00 | 15,000 | 0 | 18,500 | 3.5 K to 18.5 K (+428.57 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 12.70 | 3,361 | 42,685 | 69,597 | 73 K to 69.6 K (-4.61 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 12.70 | 5,237 | 66,510 | 77,083 | 82.3 K to 77.1 K (-6.36 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 12.70 | 5,700 | 72,390 | 89,167 | 94.9 K to 89.2 K (-6.01 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 12.70 | 8,084 | 102,667 | 214,786 | 222.9 K to 214.8 K (-3.63 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 12.70 | 8,700 | 110,490 | 199,730 | 208.4 K to 199.7 K (-4.17 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 12.70 | 3,361 | 42,685 | 69,597 | 73 K to 69.6 K (-4.61 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 12.70 | 5,237 | 66,510 | 77,083 | 82.3 K to 77.1 K (-6.36 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 12.70 | 5,700 | 72,390 | 89,167 | 94.9 K to 89.2 K (-6.01 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 12.70 | 8,084 | 102,667 | 214,786 | 222.9 K to 214.8 K (-3.63 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 12.70 | 8,700 | 110,490 | 199,730 | 208.4 K to 199.7 K (-4.17 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 21,750 | 0 | 208,430 | 186.7 K to 208.4 K (+11.65 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 10,500 | 0 | 72,958 | 62.5 K to 73 K (+16.81 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 19,500 | 0 | 222,870 | 203.4 K to 222.9 K (+9.59 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 14,250 | 0 | 94,867 | 80.6 K to 94.9 K (+17.68 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 13,500 | 0 | 82,320 | 68.8 K to 82.3 K (+19.62 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 7,500 | 0 | 10,500 | 3 K to 10.5 K (+250.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 7,500 | 0 | 16,830 | 9.3 K to 16.8 K (+80.39 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 29,250 | 0 | 80,617 | 51.4 K to 80.6 K (+56.94 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 29,250 | 0 | 68,820 | 39.6 K to 68.8 K (+73.92 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 58,500 | 0 | 203,370 | 144.9 K to 203.4 K (+40.38 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 27,000 | 0 | 62,458 | 35.5 K to 62.5 K (+76.15 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 63,000 | 0 | 186,680 | 123.7 K to 186.7 K (+50.94 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Sell | S | 14.22 | 3,000 | 42,660 | 3,000 | 6 K to 3 K (-50.00 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 14.22 | 1,081 | 15,372 | 35,458 | 36.5 K to 35.5 K (-2.96 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 14.22 | 3,040 | 43,229 | 144,870 | 147.9 K to 144.9 K (-2.06 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 14.22 | 4,000 | 56,880 | 123,680 | 127.7 K to 123.7 K (-3.13 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 13.77 | 11,000 | 151,470 | 51,367 | 62.4 K to 51.4 K (-17.64 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 14.22 | 3,333 | 47,395 | 62,367 | 65.7 K to 62.4 K (-5.07 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 14.22 | 16,291 | 231,658 | 39,570 | 55.9 K to 39.6 K (-29.16 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 14.22 | 2,100 | 29,862 | 9,330 | 11.4 K to 9.3 K (-18.37 %) |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Option Exercise | M | 4.30 | 39,478 | 169,755 | 39,479 | |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Buy | M | 4.30 | 39,478 | 169,755 | 147,910 | 108.4 K to 147.9 K (+36.41 %) |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | M | 4.30 | 23,255 | 99,997 | 121,838 | |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Buy | M | 4.30 | 23,255 | 99,997 | 127,680 | 104.4 K to 127.7 K (+22.27 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 23.58 | 4,351 | 102,591 | 108,432 | 112.8 K to 108.4 K (-3.86 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 112,783 | 99.8 K to 112.8 K (+13.03 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 23.58 | 2,461 | 58,027 | 36,539 | 39 K to 36.5 K (-6.31 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 7,000 | 0 | 39,000 | 32 K to 39 K (+21.88 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 23.58 | 4,139 | 97,593 | 55,861 | 60 K to 55.9 K (-6.90 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 60,000 | 51 K to 60 K (+17.65 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 23.58 | 5,075 | 119,662 | 104,425 | 109.5 K to 104.4 K (-4.63 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,500 | 0 | 109,500 | 95 K to 109.5 K (+15.26 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 23.58 | 3,800 | 89,599 | 65,700 | 69.5 K to 65.7 K (-5.47 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 9,500 | 0 | 69,500 | 60 K to 69.5 K (+15.83 %) |
| Jun 21 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 25.00 | 4,595 | 114,875 | 51,000 | 55.6 K to 51 K (-8.27 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.09 | 25 | 377 | 55,595 | 55.6 K to 55.6 K (-0.04 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.05 | 1,186 | 17,849 | 55,620 | 56.8 K to 55.6 K (-2.09 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.08 | 17 | 256 | 56,806 | 56.8 K to 56.8 K (-0.03 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.10 | 1,428 | 21,563 | 56,823 | 58.3 K to 56.8 K (-2.45 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.15 | 732 | 11,090 | 58,251 | 59 K to 58.3 K (-1.24 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.20 | 17 | 258 | 58,983 | 59 K to 59 K (-0.03 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.09 | 22 | 332 | 99,783 | 99.8 K to 99.8 K (-0.02 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.05 | 1,082 | 16,284 | 99,805 | 100.9 K to 99.8 K (-1.07 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.08 | 16 | 241 | 100,887 | 100.9 K to 100.9 K (-0.02 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.10 | 1,302 | 19,660 | 100,903 | 102.2 K to 100.9 K (-1.27 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.15 | 668 | 10,120 | 102,205 | 102.9 K to 102.2 K (-0.65 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.20 | 16 | 243 | 102,873 | 102.9 K to 102.9 K (-0.02 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.05 | 1,752 | 26,368 | 95,000 | 96.8 K to 95 K (-1.81 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.08 | 32 | 482 | 96,752 | 96.8 K to 96.8 K (-0.03 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.10 | 2,104 | 31,770 | 96,784 | 98.9 K to 96.8 K (-2.13 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.15 | 1,082 | 16,392 | 98,888 | 100 K to 98.9 K (-1.08 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.20 | 30 | 456 | 99,970 | 100 K to 100 K (-0.03 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Option Exercise | A | 15.10 | 35,000 | 528,500 | 35,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Option Exercise | A | 15.10 | 47,500 | 717,250 | 47,500 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 6,000 | 0 | 11,430 | 5.4 K to 11.4 K (+110.50 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Option Exercise | A | 15.10 | 65,000 | 981,500 | 65,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 15.10 | 72,500 | 1,094,750 | 72,500 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 15.10 | 45,000 | 679,500 | 45,000 | |
| Jun 29 2016 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Buy | P | 13.00 | 76,923 | 999,999 | 1,187,365 | 1.1 M to 1.2 M (+6.93 %) |
| Jun 29 2016 | PRTK | Paratek Pharmaceut ... | Lim Richard J. | Director | Buy | P | 13.00 | 384,615 | 4,999,995 | 779,802 | 395.2 K to 779.8 K (+97.32 %) |
| Jun 29 2016 | PRTK | Paratek Pharmaceut ... | Omega Fund III, L.P. | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 779,802 | 395.2 K to 779.8 K (+97.32 %) |
| Jun 29 2016 | PRTK | Paratek Pharmaceut ... | Omega Fund III, L.P. | 10% Owner | Buy | P | 13.00 | 76,923 | 999,999 | 1,187,365 | 1.1 M to 1.2 M (+6.93 %) |
| Jun 27 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Buy | P | 13.45 | 20,000 | 269,014 | 100,000 | 80 K to 100 K (+25.00 %) |
| Mar 31 2016 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 15.17 | 20,000 | 303,400 | 20,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 14.05 | 60,000 | 843,000 | 60,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 30,000 | 0 | 80,000 | 50 K to 80 K (+60.00 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Option Exercise | A | 14.05 | 22,000 | 309,100 | 22,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 11,000 | 0 | 32,000 | 21 K to 32 K (+52.38 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | A | 14.05 | 45,000 | 632,250 | 45,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Grant | A | 0.00 | 22,500 | 0 | 102,889 | 80.4 K to 102.9 K (+27.99 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 14.05 | 48,000 | 674,400 | 48,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 24,000 | 0 | 59,000 | 35 K to 59 K (+68.57 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Option Exercise | A | 14.05 | 50,000 | 702,500 | 50,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 25,000 | 0 | 60,000 | 35 K to 60 K (+71.43 %) |
| Dec 14 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 16.67 | 900 | 15,003 | 80,389 | 79.5 K to 80.4 K (+1.13 %) |
| Dec 14 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 17.00 | 1,400 | 23,800 | 79,489 | 78.1 K to 79.5 K (+1.79 %) |
| Nov 18 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 16.16 | 3,700 | 59,792 | 78,089 | 74.4 K to 78.1 K (+4.97 %) |
| Aug 04 2015 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 25.16 | 20,000 | 503,200 | 20,000 | |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | A | 25.77 | 60,000 | 1,546,200 | 60,000 | |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Grant | A | 0.00 | 30,000 | 0 | 74,389 | 44.4 K to 74.4 K (+67.58 %) |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 25.77 | 100,000 | 2,577,000 | 100,000 | |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Option Exercise | A | 25.77 | 130,000 | 3,350,100 | 130,000 | |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 20,000 | 0 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 30.25 | 3,700 | 111,934 | 1,747,680 | 1.8 M to 1.7 M (-0.21 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 29.52 | 6,300 | 185,973 | 1,751,380 | 1.8 M to 1.8 M (-0.36 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 32.16 | 2,365 | 76,048 | 1,757,680 | 1.8 M to 1.8 M (-0.13 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 31.52 | 8,215 | 258,937 | 1,760,045 | 1.8 M to 1.8 M (-0.46 %) |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | J | 4.30 | 145,093 | 623,900 | 145,093 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | J | 4.30 | 145,093 | 623,900 | 145,093 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 24.07 | 20,000 | 481,400 | 20,000 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.07 | 160,000 | 3,851,200 | 160,000 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.07 | 35,000 | 842,450 | 35,000 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 24.07 | 20,000 | 481,400 | 20,000 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 24.07 | 20,000 | 481,400 | 20,000 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 48.84 | 1,125 | 54,945 | 0 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 82.20 | 583 | 47,923 | 0 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 90.24 | 583 | 52,610 | 0 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 80.88 | 158 | 12,779 | 0 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 82.56 | 333 | 27,492 | 0 | |
| Oct 30 2014 | PRTK | Paratek Pharmaceut ... | Nunn Jason Raleigh | Director | Option Exercise | D | 38.04 | 833 | 31,687 | 0 |